Extramammary Paget disease is characterized by the consistent lack of estrogen and progesterone receptors but frequently expresses androgen receptor

American Journal of Clinical Pathology

Volumn 113, Issue 4, 2000, Pages 572-575

  De Leon, Emma Diaz ^c   Carcangiu, Maria Luisa ^c   Prieto, Victor G ^c   McCue, Peter A ^a   Burchette, James L ^c   To, Gia ^c   Norris, Brent A ^c   Kovatich, Albert J ^a   Sanchez, Ramon L ^c   Krigman, Hannah R ^c   Gatalica, Zoran ^b  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c NONE

Author keywords

Extramammary Paget disease; Immunohistochemistry; Skin neoplasms; Steroid hormone receptors

Indexed keywords

ANDROGEN RECEPTOR; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; APOCRINE CARCINOMA; ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MALE; PAGET SKIN DISEASE; PRIORITY JOURNAL;

EID: 0034049669     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/p756-xxcb-tv71-u4xv     Document Type: Article

References (25)

1. Wick MR, Swanson PE. Cutaneous Adnexal Tumors. Chicago, IL: ASCP Press; 1991:19-21.
2. Murphy GF, Elder DE. Non-melanocytic Tumors of the Skin. Atlas of Tumor Pathology. Third Series, Fascicle 1. Washington, DC: Armed Forces Institute of Pathology; 1990:117-119.
3. Cappuccini F, Tewari K, Rogers LW, et al. Extramammary Paget's disease of the vulva: metastases to the bone marrow in the absence of an underlying adenocarcinoma: case report and literature review. Gynecol Oncol. 1997;66:146-150.
4. Hart WR, Millman JB. Progression of intraepithelial Paget's disease ot the vulva to invasive carcinoma. Cancer. 1977;40:2323-2337.
5. Sarmieto JM, Wolft BG, Burgart LJ, et al. Paget's disease of the perianal region: an aggressive disease? Dis Colon Rectum. 1997;40:1187-1194.
6. Kurzl RG. Paget's disease. Semin Dermatol. 1996;15: 60-66.
7. Tsukada Y, Lopez R, Pickren JW, et al. Paget's disease of vulva: a clinicopathologic study of eight cases. Obstet Gynecol. 1975;45:73-78.
8. Burrows NP, Jones DH, Hudson PM, et al. Treatment of extramammary Paget's disease by radiotherapy. Br J Dermatol. 1995;132:970-972.
9. Choudry R, Hodgins MR, Van der Kwast TH, et al. Localization of androgen receptors in human skin by immunohistochemistry: implication tor the hormonal regulation of hair growth, sebaceous glands and sweat glands. J Endocrinol. 1992;133:467-475.
10. Gatalica Z. Immunohistochemical analysis of apocrine breast lesions: consistent over-expression ot androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ. Pathol Res Pract. 1997;193:753-758.
11. Fanning J, Lambert L, Hale TM, et al. Paget's disease of the vulva: prevalence of associated vulvar adenocarcinoma, invasive Paget's disease, and recurrence after surgical excision. Am J Obstet Gynecol. 1999;180:24-27.
12. Requena L, Sanchez Yus E, Nunez C., et al. Epidermotropically metastatic breast carcinomas: rare histopathologic variants mimicking melanoma and Pager's disease. Am J Dermatopathol. 1996;18:385-395.
13. Kohler S, Rouse RV, Smoller BR. The differential diagnosis of Pagetoids cells in the epidermis. Mod Pathol. 1998;11:79-92.
14. Ramachandra S, Gillett CE, Millis RR. A comparative immunohistochemical study of mammary and extramammary Paget's disease and superficial spreading melanoma, with particular emphasis on melanocytic markers. Virchows Arch. 1996;429:371-376.
15. Battles OE, Page PL, Johnson JE. Cytokeratins, CEA, and mucin histochemistry in the diagnosis and characterization of extramammary Paget's disease. Am J Clin Pathol. 1997;108:6-12.
16. Nakamura G, Shikata N, Shoji T, et al. Immunohistochemical study of mammary and extramammary Paget's disease. Anticancer Res. 1995;15: 467-470.
17. Swanson PE, Mazoujian G, Mills SE, et al. Immunoreactivity tor estrogen and progesterone receptor protein in sweat gland tumors. Am J Surg Pathol. 1991;15:835-841.
18. Lloveras B, Googe PB, Goldberg DE, et al. Estrogen receptors in skin appendage tumors and extramammary Paget's disease. Mod Pathol. 1991;4:487-490.
19. Iwamura VI, Abrahamsson P, Benning CM, et al. Androen receptor immunostaining and its tissue distribution in formalin-fixed, paraffin-embedded sections after microwave treatment. J Histochem Cytochem. 1994;42:783-788.
20. Shikata N, Kurokawa I, Andachi H, et al. Expression of androen receptors in skin appendage tumors: an inimunohistochcmical study. J Cutan Pathol. 1995;22: 149-153.
21. Pertschuk LP, Feldman JG, Kim YD, et al. Estrogen receptor immunohistochemistry in paraffin embedded tissues with ER1D5 predicts endocrine response more accurately than H222Spγ in frozen sections or cytosol based ligand binding assays. Cancer. 1996:77:2514-2519.
22. Nishi M, Tashiro M, Yoshida H. Stimulation of growth by both androgen and estrogen of the EMP-K1 transplantable tumor with androgen and estrogen receptors from human extramammary Paget's disease in nude mice. J Natl Cancer Inst. 1992;84:519-525.
23. Birrell SN, Bentel JM, Hickey TE, et al. Androgens induce divergent proliferative responses in human breast cancer cell lines. J Steroid Biochem Mol Biol. 1995;52:459-467.
24. Hall RE, Birrell SN, Tilley WD, et al. MDA-MB-453, an androgen-responsive human breast carcinoma cell line with high level androgen receptor expression. Eur J Cancer. 1994;30A:484-490.
25. Birell SN, Roder DM, Horsfall DJ, et al. Medroxyprogesterone acetate therapy in advanced breast cancer: the predictive value of androgen receptor expression. J Clin Oncol. 1995;13:1572-1577.